Which works better: one antibiotic or two for this superbug?

NCT ID NCT07593547

Recruiting now Knowledge-focused Sponsor: Instituto de Investigación Sanitaria Gregorio Marañón Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 790 adults with S. maltophilia infections, a hard-to-treat bacteria. Researchers will compare patients who got one antibiotic versus those who got a combination, to see which group has fewer deaths within 30 days. The goal is to find the best treatment approach using real-world data.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors choose the best treatment strategy for S. maltophilia infections, potentially reducing deaths.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. It does not test a new drug, only compares existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOODSTREAM INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis bacterial pneumonia Infections Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOODSTREAM INFECTION PNEUMONIA, BACTERIAL S MALTOPHILIA INFECTIONS S. MALTOPHILIA INFECTION

Contacts and locations

Locations

Microbiology and Infectious Disease Department, Hospital General Universitario Gregorio Marañón
RECRUITING

Madrid, Madrid, 28007, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.